Use Code - NEW70 to get flat Rs.70/- Off on orders above 699/-.
Rx Prescription Required
Salt Composition Timolol (0.5% w/v) + Brimonidine (0.2% w/v)
Therapeutic Class Opthalmic
Manufacture Alembic Pharmaceuticals Ltd
Pack Size 5ML Drop
₹136.00
Gold Card
₹ 133
Unlock
Get Upto 30% Off On Medicines with Prepay offers.
24 Hours Express Delivery
It is used for the treatment of pressure in the eyes (ocular hypertension) and glaucoma. It works by decreasing the pressure of fluid in the eye (aqueous humor), which helps in lowering the increased eye pressure. Ocular hypertension or open angle glaucoma, Glaucoma ,Hypertension.
| Weight | 0.1 kg |
|---|---|
| Pack Size | 5ML |
| Pack Form | Drop |
| Country of origin | India |
Due to systemic absorption of ophthalmic preparations, adverse reactions associated with systemic administration of β-blockers may occur. Abrupt withdrawal of beta-blocker may cause exacerbation of angina, and myocardial infarctions have occurred in some cases. Patients on long-term treatment (particularly in those with ischaemic heart disease) should discontinue medication gradually over a period of 1-2 wk. May mask signs and symptoms of hypoglycaemia, hyperthyroidism. Abrupt withdrawal may precipitate thyroid storm in patients suspected of developing thyrotoxicosis. Ophthalmic Timolol should not be used alone for treatment of angle-closure glaucoma. β-blocker therapy may increase sensitivity towards allergen in patients with history of atrophy or severe anaphylaxis reactions. May rarely increase muscle weakness in some patients with myasthenia gravis. Caution in patients undergoing major surgery; cerebrovascular insufficiency, heart failure, renal or hepatic impairment, pregnancy and lactation. Safety and efficacy have not been established in paediatric patients.,As advised by the physician.
Fatigue, headache, coldness of extremities, paraesthesia, GI symptoms, dyspnoea, skin rash, alopecia, dry mouth, bradycardia. Ophthalmic use: Burning, stinging, blurred vision, ocular irritation (e.g. conjunctivitis, blepharitis, crusting), decreased corneal sensitivity, visual disturbances, diplopia, ptosis, cystoid macular oedema, pseudopemphigoid, choroidal detachment following filtration surgery. Adverse reactions associated with systemic administration of β-blocker may occur with ophthalmic use. Potentially Fatal: Heart failure, intensification of heart block, bronchospasm, respiratory failure.
Present or history of bronchial asthma, severe COPD, sinus bradycardia, 2nd and 3rd degree heart block, sick sinus syndrome, overt heart failure, cardiogenic shock, severe peripheral vascular disease/Raynaud’s disease), Prinzmetal angina, untreated pheochromocytoma, metabolic acidosis, hypotension.
Save: 43.7%
Payment Secured by 128/256 SSL Encryption
Download App
